课题基金 / 基金详情

Mitochondrial delivery of DNA-alkylating anticancer agents

Mitochondrial delivery of DNA-alkylating anticancer agents
DNA 烷基化抗癌药物的线粒体递送
批准号:
238344
负责人:
Kelley Shana O
金额:
$37.49万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2011
资助国家:
加拿大
项目状态:
已结题
起止时间:
2011-09-01 至 2015-09-01

项目摘要

项目成果

Kelley Shana O的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We are developing compounds that evade the resistance mechanisms that cancer cells use to override the effects of anticancer therapies. By delivering the drug to a unique site within the cell, therapeutic molecules are hidden from deactivators and made m
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of integrated bioanalyte sensors for process monitoring in closed system bioreactors
  • 批准号:
    376877
  • 项目类别:
    Operating Grants
  • 资助金额:
    $30.53万
  • 财政年份:
    2017
  • 负责人:
    Kelley Shana O
  • 依托单位:
Development of non-invasive diagnostics for disease prevention and control
  • 批准号:
    333713
  • 项目类别:
    Operating Grants
  • 资助金额:
    $172.33万
  • 财政年份:
    2015
  • 负责人:
    Kelley Shana O
  • 依托单位:
Analysis of Circulating Tumor Cell Heterogeneity Using a Multi-Marker Microscale Capture Approach as a tool in the Management and Treatment of Cancer
  • 批准号:
    337040
  • 项目类别:
    Operating Grants
  • 资助金额:
    $25.12万
  • 财政年份:
    2015
  • 负责人:
    Kelley Shana O
  • 依托单位:
The xViva CTC capture chip: a device for tumor cell sorting and classification
  • 批准号:
    308147
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.66万
  • 财政年份:
    2014
  • 负责人:
    Kelley Shana O
  • 依托单位:
海外基金